Published in Biotherapy on January 01, 1996
Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis. Clin Exp Immunol (2004) 0.88
Immune response of mice with alveolar echinococcosis to therapy with transfer factor, alone and in combination with albendazole. Parasitol Res (2009) 0.81
Preparation and properties of the specific anti-influenza virus transfer factor. Head Face Med (2010) 0.77
Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection. BMC Res Notes (2011) 0.76
Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med (1971) 4.41
Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis. J Immunol (1968) 2.59
Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am J Med (1983) 2.35
Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med (1980) 2.14
The immunology of mycobacterial diseases. Am Rev Respir Dis (1986) 1.96
Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. Ann Intern Med (1974) 1.87
Simultaneous characterization of free Candida antigens and Candida precipitins in a patient's serum by means of crossed immunoelectrophoresis with intermidiate gel. J Immunol Methods (1973) 1.67
Effect of transfer factor on lymphocyte function in anergic patients. J Clin Invest (1972) 1.52
Lactoferrin--specific localization in the nuclei of human polymorphonuclear neutrophilic leukocytes. Proc Soc Exp Biol Med (1971) 1.47
Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin Exp Immunol (1970) 1.45
Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis (1971) 1.43
Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections. Ann Intern Med (1973) 1.42
Progressive immunodeficiency in a patient with IgA deficiency. Ann Allergy Asthma Immunol (1997) 1.41
Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy. Ann Intern Med (1974) 1.36
Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. J Immunol (1976) 1.35
Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings. Clin Exp Immunol (1974) 1.28
Chemotactic activity in dialyzable transfer factor. Proc Natl Acad Sci U S A (1974) 1.26
Effects of levamisole on normal and abnormal leukocyte locomotion. J Clin Invest (1977) 1.23
Acquired immunodeficiency syndrome in a patient with hemophilia. Ann Intern Med (1983) 1.19
Autoimmune vitiligo: detection of antibodies to melanin-producing cells. N Engl J Med (1977) 1.17
IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections. J Immunol (1980) 1.16
Hypogammaglobulinemia with nodular lymphoid hyperplasia of the small bowel. Arch Intern Med (1968) 1.16
Disorders of phagocyte chemotaxis. Ann Intern Med (1980) 1.15
Immology of the mycoses. II. Characterization of the immunoglobulin and antibody responses in histoplasmosis. J Infect Dis (1969) 1.12
The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners. J Clin Immunol (1987) 1.08
Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J Am Coll Cardiol (1991) 1.08
Comparison of the contact allergenicity of the four pentadecylcatechols derived from poison ivy urushiol in human subjects. J Allergy Clin Immunol (1972) 1.07
Immune response to Trichinella spiralis in the rat. I. Development of cellular and humoral responses during chronic infection. Int Arch Allergy Appl Immunol (1975) 1.06
Ketoconazole and the liver. Lancet (1982) 1.04
Indomethacin-responsive mononuclear cell dysfunction in "atypical" mycobacteriosis. Cell Immunol (1982) 1.04
Treatment of fungal infections in the bones and joints with ketoconazole. J Infect Dis (1983) 1.03
Radiologic findings of adult primary immunodeficiency disorders. Contribution of CT. Chest (1994) 1.00
Deposition of complement components in the cutaneous lesions of chronic mucocutaneous candidiasis. Clin Immunol Immunopathol (1976) 0.97
Immunologic studies in human organ transplantation. IV. Serologic and pathologic studies following heterotransplantation of the kidney. Am J Pathol (1967) 0.97
Recurrent severe infections in a child with abnormal leukocyte function: possible relationship to increased microtubule assembly. Blood (1978) 0.97
Morphologic and functional properties of the atypical T lymphocytes of the Sezary syndrome. Mayo Clin Proc (1974) 0.95
Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution. Clin Exp Immunol (1971) 0.94
Interleukin-2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome. J Clin Immunol (1985) 0.93
Mucocutaneous candidiasis and thymoma. Am J Med (1979) 0.92
Age-related and thymus-dependent rejection of adenovirus 2-transformed cell tumors in the Syrian hamster. Cancer Res (1979) 0.92
Reconstitution of defective cellular immunity with foetal thymus and dialysable transfer factor. Long-term studies in a patient with chronic mucocutaneous candidiasis. Clin Exp Immunol (1976) 0.90
Transfer of delayed cutaneous hypersensitivity with transfer factor. Cell Immunol (1978) 0.90
Properties and activities of transfer factor. J Allergy Clin Immunol (1975) 0.90
Chronic pulmonary disease and immunologic deficiency. Am J Med (1966) 0.89
Release of E-rosette augmenting factor (E-RAF) after stimulation of human leukocytes with mitogens or antigens. J Immunol (1979) 0.89
Mycobacterium avium-intracellulare: cutaneous presentations of disseminated disease. Am J Med (1988) 0.88
Host factors in defense against fungal infections. Am J Med (1984) 0.88
Epidermal proliferation in the defense against experimental cutaneous candidiasis. J Invest Dermatol (1978) 0.88
The two-step leukocyte migration inhibition factor (LIF) assay. Its use in evaluation of cellular immune function in patients with immunodeficiency diseases. Cell Immunol (1978) 0.87
The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men. Cell Immunol (1986) 0.86
Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor. J Clin Invest (1975) 0.86
Calcinosis, Raynaud's phenomenon, sclerodactyly, and telangiectasia. The CRST syndrome. Arch Intern Med (1967) 0.85
Subacute encephalitis and congenital hypogammaglobulinemia. Arch Neurol (1972) 0.85
Rejection of adenovirus 2-transformed cell tumors and immune responsiveness in Syrian hamsters. Cancer Res (1979) 0.85
Simultaneous suppression of responses to allogeneic tissue in vitro and in vivo. Cell Immunol (1972) 0.85
Deposition of complement in the lesions of experimental cutaneous candidiasis in guinea pigs. J Cutan Pathol (1976) 0.84
The pathogenesis of trehalose dimycolate-induced interstitial pneumonitis. III. Evidence for a role for T lymphocytes. Cell Immunol (1984) 0.84
Restoration of cell-mediated immune responses with transfer factor. Birth Defects Orig Artic Ser (1975) 0.83
The pathogenesis of interstitial pneumonitis induced by trehalose dimycolate. II. Reserpine prevents formation of lesions. Am Rev Respir Dis (1984) 0.83
Cellular immunity in Peyer's patches of rats infected with Trichinella spiralis. Infect Immun (1976) 0.82
Treatment of infectious and neoplastic diseases with transfer factor. Oncology (1974) 0.82
Interstitial and hemorrhagic pneumonitis induced by mycobacterial trehalose dimycolate. Am J Pathol (1982) 0.82
Treatment of chronic oral candidiasis with clotrimazole troches. A controlled clinical trial. N Engl J Med (1978) 0.82
Modulation of immunologic responses in nontuberculous mycobacterial infections with indomethacin. J Clin Immunol (1984) 0.82
Study of possible mechanisms of basophil accumulation in experimental cutaneous candidiasis in guinea pigs. J Allergy Clin Immunol (1977) 0.82
Purification of transfer factors. Mol Immunol (1992) 0.81
Subpopulations of human T lymphocytes. XI. T cells with receptors for IgM or IgG and locomotion of T and non-T cells in peripheral blood from patients with chronic mucocutaneous candidiasis. Clin Immunol Immunopathol (1979) 0.81
Murine transfer factor. I. Description of the model and evidence for specificity. J Immunol (1981) 0.81
Impaired responsiveness to epinephrine in asthma. Am Rev Respir Dis (1967) 0.81
Suppression of cellular immune responses following transfer factor: report of a case. Cell Immunol (1975) 0.81
Immunosuppressive therapy. Postgrad Med (1970) 0.80
Comparison of antibody responses in chronic mucocutaneous candidiasis and tinea versicolor. Int Arch Allergy Appl Immunol (1980) 0.80
Treatment of chronic mucocutaneous candidosis with ketoconazole: preliminary results of a controlled, double-blind clinical trial. Rev Infect Dis (1981) 0.80
Murine transfer factor. II. Transfer of delayed hypersensitivity to synthetic antigens. J Immunol (1985) 0.80
Paternal immunoglobulin abnormalities in congenital hypogammaglobulinemia. JAMA (1967) 0.80
Immunosuppressive activity of cord blood leukocytes. Pediatrics (1980) 0.80
Immunologic reconstitution in a patient with keratoconjunctivitis, superficial candidiasis and hypoparathyroidism: the role of immunocompetent lymphocyte transfusion and transfer factor. Trans Am Ophthalmol Soc (1973) 0.79
Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome. Cancer Res (1986) 0.79
Dermatophytosis in patients with chronic mucocutaneous candidiasis. J Am Acad Dermatol (1980) 0.79
Corneal cellular immunity in the guinea pig. Am J Pathol (1974) 0.79
Photosensitive cheilitis. Clinical and pathogenetic considerations. Ann Intern Med (1971) 0.79
The lack of effect of transfer factor in thymic dysplasia with immunoglobulin synthesis. J Pediatr (1974) 0.79
Mechanism of allergy to components of commercial bovine thyrotropin. J Allergy Clin Immunol (1973) 0.78
Plasma thymic hormone activity in patients with chronic mucocutaneous candidiasis. Clin Exp Immunol (1978) 0.78
Lymphokines and platelets promote human monocyte adherence to fibrinogen and fibronectin in vitro. J Leukoc Biol (1987) 0.78
A microtiter assay for human monocyte activation by lymphokines. J Immunol Methods (1984) 0.78
Methionine-enkephalin as immunomodulator therapy in human immunodeficiency virus infections: clinical and immunological effects. J Clin Immunol (1988) 0.78
Recognition of the immunocompromised patient. Chest Surg Clin N Am (1999) 0.78
Therapeutic potential of transfer factor. N Engl J Med (1980) 0.77
Ability of dialysates containing transfer factor to induce lymphocyte activating factor by human mononuclear cells. Cell Immunol (1979) 0.77
Transfer of cellular immunity with transfer factor. J Allergy Clin Immunol (1979) 0.77
Immunologic deficiency in the congenital rubella syndrome. Am J Dis Child (1969) 0.76
The nature of transfer factor and its clinical efficacy in the management of cutaneous disorders. J Invest Dermatol (1976) 0.76
Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia. Transplant Proc (1974) 0.76
The acquired immunodeficiency syndrome and a trimethoprim-sulfamethoxazole adverse reaction. Ann Intern Med (1984) 0.75
The E-rosette augmenting factor (E-RAF): aspects of clinical application. Clin Exp Immunol (1980) 0.75
Phenotypes of infiltrating cells in trehalose dimycolate-induced interstitial pneumonitis. Infect Immun (1989) 0.75
Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial. Clin Exp Immunol (2014) 0.75
A man with multiple infections with unusual organisms. Ann Allergy Asthma Immunol (1999) 0.75
Nature and activities of transfer factor. Ann N Y Acad Sci (1979) 0.75